Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Otsuka Pharma Scandinavia AB
AB
Active
Org 5566158134
Sveavägen 151, 113 46
Stockholm
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2001 · 24 years old
39 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Otsuka Pharma Scandinavia AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
457M
343M
229M
114M
0M
2020: 299M
299M
2020
2021: 285M (-5% vs 2020)
285M
-5%
2021
2022: 322M (+13% vs 2021)
322M
+13%
2022
2023: 335M (+4% vs 2022)
335M
+4%
2023
2024: 367M (+10% vs 2023)
367M
+10%
2024
EBITDA
SEK millions
15M
11M
7M
4M
0M
2020: 7M
7M
2020
2021: 10M (+43% vs 2020)
10M
+43%
2021
2022: 12M (+20% vs 2021)
12M
+20%
2022
2023: 9M (-25% vs 2022)
9M
-25%
2023
2024: 10M (+11% vs 2023)
10M
+11%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
367 404
334 858
321 713
285 068
298 763
Staff expenses
—
—
—
—
—
EBITDA
10 231
8 874
12 142
9 885
7 052
Depreciation & amort.
−477
−301
−382
−453
−1 036
EBIT
9 754
8 573
11 760
9 432
6 016
Net financials
639
538
13
−205
−132
Profit before tax
10 393
9 111
11 773
9 227
5 923
Tax
−2 913
−2 451
−2 907
−2 120
−1 493
Net profit
7 480
6 660
8 866
7 107
4 430
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
136 409
131 928
121 328
103 287
103 252
Equity
49 895
49 015
51 220
49 354
44 462
Long-term debt
0
0
0
0
0
Short-term debt
86 514
82 913
70 108
53 933
58 790
Total debt
86 514
82 913
70 108
53 933
58 790
Financial ratios
5-year trend
EBITDA margin
2,8 %
This company
15,8 %
Market median
This company
Market median
82% below market
2020
2024
Equity ratio
36,6 %
This company
38,2 %
Market median
This company
Market median
4% below market
2020
2024
Return on equity
15,0 %
This company
18,4 %
Market median
This company
Market median
18% below market
2020
2024
Net profit margin
2,0 %
This company
8,1 %
Market median
This company
Market median
75% below market
2020
2024
Asset turnover
2,69×
This company
1,12×
Market median
This company
Market median
140% above market
2020
2024
Debt / equity
1,73×
This company
0,62×
Market median
This company
Market median
179% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Otsuka Pharma Scandinavia AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
